You Position: Home > Paper
经导航支气管镜局部灌注两性霉素B治愈肺毛霉病一例
( views:261, downloads:147 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Tuberculosis and Respiratory Diseases
- Issue:
- 8
- DOI:
- 10.3760/cma.j.cn112147-20210104-00005
- Key Word:
- No keyword available
Abstract： 本文报道1例通过虚拟导航支气管镜导航经支气管镜局部精准灌注两性霉素B成功治疗肺毛霉病的患者。本例患者在糖尿病酮症酸中毒后2周出现咳嗽、咳痰、咯血，影像学表现为左下肺新发团片状高密度影伴晕征，组织病理及二代基因测序证实为毛霉感染。通过虚拟导航支气管镜于左肺病变部位精准灌注两性霉素B两次，成功治愈肺毛霉病。
- [1]李妍.慢性阻塞性肺疾病相关肺动脉高压患者的临床特征及危险因素分析[D].2020.
- [2]杨苏乔,杨媛华,邝土光,等.门脉高压性肺动脉高压临床特点及靶向药物治疗分析[J].2019,(36).
- [3]Shuang, Dou,Chunyan, Zheng,Xiuli, Ji,etc.Co-existence of COPD and bronchiectasis: a risk factor for a high ratio of main pulmonary artery to aorta diameter (PA:A) from computed tomography in COPD patients.[J].2018,13(Spec ).
- [4]Thenappan, Thenappan,Mark L, Ormiston,John J, Ryan,etc.Pulmonary arterial hypertension: pathogenesis and clinical management.[J].2018,360(Spec ).
- [5]Isabelle,Opitz,Silvia,Ulrich.Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery.[J].2018,10(Suppl 23).
- [6]Simonneau, Gerald,Montani, David,Celermajer, David S.,etc.Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J].2019,53(1).
- [7]Foris,V.,Kovacs,G.,Olschewski,H.,etc.Biomarkers in pulmonary hypertension: What do we know?[J].2013,144(1).
- [8]Kane GC,Enders FT,Redfield MM,etc.Age-associated increases in pulmonary artery systolic pressure in the general population.[J].2009,119(20).
- [9]Hoeper, Marius,Lancellotti, Patrizio,Lang, Irene,etc.2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorse[J].2016,(1).
- [10]Steven J,Cassady,Robert M,Reed.Pulmonary Hypertension in COPD: A Case Study and Review of the Literature.[J].2019,55(8).
- [11]Davide,Elia,Antonella,Caminati,Maurizio,Zompatori,etc.Pulmonary hypertension and chronic lung disease: where are we headed?[J].2019,28(153).
- [12]Charlotte, Andersen,S?ren, Mellemkj?r,Ole, Hilberg,etc.NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease.[J].2016.
- [13]Huanhuan,Zuo,Xiaochen,Xie,Jiahuan,Peng,etc.Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease.[J].2019,2019.
- [14]Dhillon G,Wang L,Agrawal R,etc.Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.[J].2011,109(8).
- [15]Nickel, Nils P.,Yuan, Ke,Dorfmuller, Peter,etc.Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension[J].2020,201(2).
- [16]Amirmasoud, Zangiabadi,Carmine G, De Pasquale,Dimitar, Sajkov.Pulmonary hypertension and right heart dysfunction in chronic lung disease.[J].2014,2014.
- [17].Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension[J].2012,126(9).